Table 2 ROC analysis of the imaging biomarkers

From: Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival

Biomarker

AUC

Sensitivity

Specificity

Threshold

ce-T1

0.600

0.60

0.60

0.65

FLAIR

0.609

0.50

0.60

0.85

rCBF (CBF-GE)

0.736

0.80

0.75

1.05

tCho/hCr

0.859

0.90

0.82

0.91

tCho/hCr + rCBF

0.864

0.90

0.91

2.06

Back to article page